A key protein, LRG1, was identified as the early cause of diabetic eye damage, and blocking it may stop the disease before ...

November is observed as Diabetic Eye Disease Awareness Month, a month dedicated to educating people about the serious eye ...

The US Food and Drug Administration (FDA) has approved aflibercept injection 8 mg (EYLEA HD) from Regeneron Pharmaceuticals ...

Diabetes is a systemic disease, which means it affects many organs, including the heart, blood vessels, nerves, kidneys and ...

Four patients in Denmark, who experienced vision loss after using Novo Nordisk's popular weight-loss and diabetes drugs ...

A long-time supporter of the St John Eye Van, UD Trucks has been formally recognised for its support of the vital regional ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

FDA approves Regeneron's Eylea HD for retinal vein occlusion, adding extended dosing options and greater flexibility across ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. | Sun Pharma has launched an eye-opening awareness push about a common—and ...

An artificial intelligence (AI)-powered lifestyle intervention app for prediabetes reduces the risk for diabetes similarly to traditional, human-led programs in adults.

A once-a-day pill could offer “more access” to weight loss medication, experts have said after a new study confirmed the ...

A compound that enables the delivery of insulin through the skin has been demonstrated in mice and minipigs. The findings, ...